Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Background The appropriate target for systolic blood pressure to reduce cardiovascular risk in older patients with hypertension remains unclear. Methods In this multicenter, randomized, controlled trial, we assigned Chinese patients 60 to 80 years of age with hypertension to a systolic blood-pressure target of 110 to less than 130 mm Hg (intensive treatment) or a target of 130 to less than 150 mm Hg (standard treatment). The primary outcome was a composite of stroke, acute coronary syndrome (acute myocardial infarction and hospitalization for unstable angina), acute decompensated heart failure, coronary revascularization, atrial fibrillation, or death from cardiovascular causes. Results Of the 9624 patients screened for eligibility, 8511 were enrolled in the trial; 4243 were randomly assigned to the intensive-treatment group and 4268 to the standard-treatment group. At 1 year of follow-up, the mean systolic blood pressure was 127.5 mm Hg in the intensive-treatment group and 135.3 mm Hg in the standard-treatment group. During a median follow-up period of 3.34 years, primary-outcome events occurred in 147 patients (3.5%) in the intensive-treatment group, as compared with 196 patients (4.6%) in the standard-treatment group (hazard ratio, 0.74; 95% confidence interval [CI], 0.60 to 0.92; P = 0.007). The results for most of the individual components of the primary outcome also favored intensive treatment: the hazard ratio for stroke was 0.67 (95% CI, 0.47 to 0.97), acute coronary…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial included nearly 20% of people with diabetes and noted decreased cardiovascular events with treatment of hypertension to a systolic blood pressure goal of <130 mmHg (39).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [39]
In the citing paper
“Participants with diabetes comprised nearly 20% of the Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial, which noted decreased cardiovascular events with treatment of hypertension to a systolic blood pressure goal of <130 mmHg (41).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [41]
In the citing paper
“Hypotension occurred more frequently in the intensive treatment group (3.4%) compared with the standard treatment group (2.6%), without signi fi cant differences in other adverse events, including dizziness, syncope, or fractures.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [34]
In the citing paper
“In this trial, the primary composite outcome of stroke, acute coronary syndrome, acute decompensated heart failure, coronary revascularization, atrial fi brillation, or death from cardiovascular causes was reduced by 26% in the intensive treatment group.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [34]
In the citing paper
“In this trial, 18.9% of patients in the intensive treatment arm and 19.4% in the standard treatment arm had a diagnosis of type 2 diabetes.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [34]
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01225-8 · Cited by 3,755
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Treatment of hypertension in patients 80 years of age or older
Beckett, N. S., Peters, R., Fletcher, A. E., Staessen, J. A., Liu, L., Dumitrascu, D., Stoyanovsky, V., Antikainen, R. L., Nikitin, Y., Anderson, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801369 · Cited by 3,092
Cited by
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
The Global Burden of Cardiovascular Diseases and Risk
Vaduganathan, M., Mensah, G. A., Turco, J. V., Fuster, V., & Roth, G. A. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.11.005 · Cited by 2,217
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
“288,291 Since relative risk reduction by BP-lowering treatment is homogeneous in any age group, whereas absolute risk reduction is larger with advancing age, 292 therapeutic inertia in older patients with isolated systolic hypertension should be avoided.”
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases
Mazzolai, L., Teixido-Tura, G., Lanzi, S., Boc, V., Bossone, E., Brodmann, M., Bura-Rivière, A., De Backer, J., Deglise, S., Della Corte, A., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae179 · Cited by 993
Martin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A. Z., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001303 · Cited by 1,080
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Das, S. R., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s010 · Cited by 486
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Das, S. R., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s010 · Cited by 465
Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease
Burnier, M., & Damianaki, A. (2023) · Circulation Research · doi:10.1161/circresaha.122.321762 · Cited by 400
Treatment of hypertension: a review
Carey, R. M., Moran, A. E., & Whelton, P. K. (2022) · JAMA · doi:10.1001/jama.2022.19590 · Cited by 455
Report on cardiovascular health and diseases in China 2021: an updated summary
HU, S.-S. (2023) · Journal of Geriatric Cardiology · doi:10.26599/1671-5411.2023.06.001 · Cited by 428
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Das, S. R., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s010 · Cited by 438
Bushnell, C., Kernan, W. N., Sharrief, A. Z., Chaturvedi, S., Cole, J. W., Cornwell, W. K., Cosby-Gaither, C., Doyle, S., Goldstein, L. B., Lennon, O., et al. (2024) · Stroke · doi:10.1161/str.0000000000000475 · Cited by 360
Writing Committee Members*, Jones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., et al. (2025) · Hypertension · doi:10.1161/hyp.0000000000000249 · Cited by 310
Palaniappan, L. P., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Currie, M. E., Earlie, R. S., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001412 · Cited by 242
Self-citationWriting Committee Members*, Jones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001356 · Cited by 213
Jones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., Bress, A. P., et al. (2025) · JACC · doi:10.1016/j.jacc.2025.05.007 · Cited by 280
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes
Bi, Y., Li, M., Liu, Y., Li, T., Lu, J., Duan, P., Xu, F., Dong, Q., Wang, A., Wang, T., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2412006 · Cited by 268
Self-citationMa, J., Li, Y., Yang, X., Liu, K., Zhang, X., Zuo, X., Ye, R., Wang, Z., Shi, R., Meng, Q., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01430-7 · Cited by 243
Self-citationLi, W., Shen, C., Kong, W., Zhou, X., Fan, H., Zhang, Y., Liu, Z., & Zheng, L. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02352-6 · Cited by 234
Self-citationLiu, J., Li, Y., Ge, J., Yan, X., Zhang, H., Zheng, X., Lu, J., Li, X., Gao, Y., Lei, L., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01028-6 · Cited by 258
Self-citationJCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E., Sato, K., Teramoto, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0002 · Cited by 191
Hypertension management in patients with cardiovascular comorbidities
Lauder, L., Mahfoud, F., Azizi, M., Bhatt, D. L., Ewen, S., Kario, K., Parati, G., Rossignol, P., Schlaich, M. P., Teo, K. K., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehac395 · Cited by 210
Self-citation10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s010 · Cited by 225
Barbato, E., Azizi, M., Schmieder, R. E., Lauder, L., Böhm, M., Brouwers, S., Bruno, R. M., Dudek, D., Kahan, T., Kandzari, D. E., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad054 · Cited by 188
Sun, Y., Mu, J., Wang, D. W., Ouyang, N., Xing, L., Guo, X., Zhao, C., Ren, G., Ye, N., Zhou, Y., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00325-7 · Cited by 164
Self-citationSchutte, A. E., Jafar, T. H., Poulter, N. R., Damasceno, A., Khan, N. A., Nilsson, P. M., Alsaid, J., Neupane, D., Kario, K., Beheiry, H., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac130 · Cited by 196
Self-citationChinese Guidelines for the Prevention and Treatment of Hypertension (2024 revision)
Wang, J. (2025) · 老年心脏病学杂志:英文版 · doi:10.26599/1671-5411.2025.01.008 · Cited by 192
Kim, H.-L., Lee, E. M., Ahn, S. Y., Kim, K.-I., Kim, H. C., Kim, J. H., Lee, H.-Y., Lee, J. H., Park, J.-M., Cho, E. J., et al. (2023) · Clinical Hypertension · doi:10.1186/s40885-023-00234-9 · Cited by 164
He, J., Ouyang, N., Guo, X., Sun, G., Li, Z., Mu, J., Wang, D. W., Qiao, L., Xing, L., Ren, G., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(22)02603-4 · Cited by 171
Self-citation2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Kim, N. H., Seo, J. A., Kim, M. K., Lim, J. H., et al. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0282 · Cited by 149
(2022) · PubMed Central · doi:10.6515/acs.202205_38(3).20220321a · Cited by 117
Self-citationAmlodipine in the current management of hypertension
Wang, J., Palmer, B. F., Anderson, K. V., & Sever, P. (2023) · Journal of Clinical Hypertension · doi:10.1111/jch.14709 · Cited by 128
Brazilian Guidelines of Hypertension – 2025
Brandão, A. A., Rodrigues, C. I. S., Bortolotto, L. A., Armstrong, A. D. C., Mulinari, R. A., Feitosa, A. D. M., Gomes, M. A. M., Barbosa, E. C. D., Moura-Neto, J. A., Neves, M. F., et al. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250624 · Cited by 153
Digital Therapeutics in Hypertension: Evidence and Perspectives
Kario, K., Harada, N., & Okura, A. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19414 · Cited by 109
Self-citationPhenotyping the hypertensive heart
Tadić, M., Cuspidi, C., & Marwick, T. H. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac393 · Cited by 108
2026 ESC Guidelines for the management of heart failure
Køber, L., Adamo, M., Ruwald, A., Tomasoni, D., Anderson, L., Andersson, C., Brugts, J. J., Chioncel, O. D., Donal, E., Ferdinandy, P., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag100 · Cited by 147
Gorostidi, M., Gijón‐Conde, T., Sierra, À., Rodilla, E., Rubio, E., Vinyoles, E., Oliveras, A., Santamaría, R., Segura, J., Molinero, A., et al. (2022) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2022.09.002 · Cited by 149
Landscape of cardiometabolic risk factors in Chinese population: a narrative review
Li, J., Liu, H., & Li, S. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01551-3 · Cited by 101
Self-citationSesa‐Ashton, G., Nolde, J. M., Muente, I., Carnagarin, R., Lee, R., Macefield, V. G., Dawood, T., Sata, Y., Lambert, É., Lambert, G. W., et al. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.20853 · Cited by 88
Kandzari, D. E., Mahfoud, F., Weber, M. A., Townsend, R., Parati, G., Fisher, N. D. L., Lobo, M. D., Bloch, M., Böhm, M., Sharp, A. S. P., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.057687 · Cited by 90
Ohya, Y., Arakawa, K., Arata, N., Arima, S., Arima, H., Asayama, K., Dohi, Y., Fukami, A., Furuhashi, M., Goto, K., et al. (2026) · Hypertension Research · doi:10.1038/s41440-025-02462-y · Cited by 106
Moon, J. S., Kang, S., Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Seo, J. A., Kim, M. K., et al. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0249 · Cited by 90
Cardiovascular Considerations After Cancer Therapy
Blaes, A. H., Nohria, A., Armenian, S. H., Bergom, C. R., Thavendiranathan, P., Barac, A., Sanchez‐Petitto, G., Desai, S., Zullig, L. L., Morgans, A. K., et al. (2025) · JACC CardioOncology · doi:10.1016/j.jaccao.2024.06.006 · Cited by 98
Hu, Y., Yu, L., Li, J., Li, X., Yu, M., & Cui, W. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02593-z · Cited by 85
Khan, S. S., Breathett, K., Braun, L. T., Chow, S. L., Gupta, D. K., Lekavich, C., Lloyd-Jones, D. M., Ndumele, C. E., Rodriguez, C. J., Allen, L. A., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001307 · Cited by 75
Jaeger, B. C., Bress, A. P., Bundy, J. D., Cheung, A. K., Cushman, W. C., Drawz, P. E., Johnson, K., Lewis, C. E., Oparil, S., Rocco, M. V., et al. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2022.3345 · Cited by 78
Revisiting secondary prevention in coronary heart disease
Sigamani, A., & Gupta, R. (2022) · Indian Heart Journal · doi:10.1016/j.ihj.2022.11.011 · Cited by 85
Optimal Antihypertensive Systolic Blood Pressure: A Systematic Review and Meta-Analysis
Whelton, P. K., O’Connell, S. S., Mills, K. T., & He, J. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.23597 · Cited by 76
Guideline for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition)
Guo, L., & Xiao, X. (2024) · Aging Medicine · doi:10.1002/agm2.12294 · Cited by 78
Chen, T., Shao, F., Chen, K., Wang, Y., Wu, Z., Wang, Y., Gao, Y., Cornelius, V. R., Li, C., & Jiang, Z. (2022) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2022.1657 · Cited by 75
Systolic Blood Pressure Time in Target Range and Major Adverse Kidney and Cardiovascular Events
Buckley, L. F., Baker, W. L., Tassell, B. W. V., Cohen, J. B., Alkhezi, O. S., Bress, A. P., & Dixon, D. L. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.20141 · Cited by 67
Clinical practice guideline for the management of hypertension in China
Chinese Society of Cardiology, C. M. A., Hypertension Committee of Cross-Straits Medicine Exchange Association, & Cardiovascular Disease Prevention and Rehabilitation Committee, C. A. O. R. M. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003431 · Cited by 68
Blood pressure targets for the treatment of people with hypertension and cardiovascular disease
Saiz, L. C., Gorricho, J., Garjón, J., Celaya, M. C., Erviti, J., & Leache, L. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010315.pub5 · Cited by 71
Alcocer, L. A., Bryce, A., Brasil, D., Lara-Terán, J. J., Cortes, J. M., Quesada, D., & Rodriguez, P. (2023) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-023-00605-5 · Cited by 70
Goupil, R., Tsuyuki, R. T., Santesso, N., Terenzi, K. A., Habert, J., Cheng, G., Gysel, S. C., Bruneau, J., Leung, A. A., Campbell, N. R. C., et al. (2025) · Canadian Medical Association Journal · doi:10.1503/cmaj.241770 · Cited by 60
Dasgupta, I., & Zoccali, C. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.18434 · Cited by 63
Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório – 2023
Feitosa, A. D. M., Barroso, W. K. S., Mion, D., Nobre, F. D., Gomes, M. A. M., Jardim, P. C. B. V., Amodeo, C., Oliveira, A. C., Alessi, A., Sousa, A. L. L., et al. (2024) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240113 · Cited by 102
Risk Factors and Cardiovascular Disease in the Elderly
Díez‐Villanueva, P., Jiménez-Méndez, C., Bonanad, C., García‐Blas, S., Pérez-Rivera, J.-Á., Miguel, G. A., García‐Pardo, H., Formiga, F., Camafort, M., Martínez‐Sellés, M., et al. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2306188 · Cited by 61
The HOPE Asia network 2022 up‐date consensus statement on morning hypertension management
Kario, K., Wang, J., Chia, Y. C., Wang, T., Li, Y., Siddique, S., Shin, J., Turana, Y., Buranakitjaroen, P., Chen, C., et al. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14555 · Cited by 54
Self-citationJCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.02.014 · Cited by 67
Rodgers, A., Salam, A., Schutte, A. E., Cushman, W. C., de Silva, H. A., Tanna, G. L. D., Grobbee, D. E., Narkiewicz, K., Ojji, D. B., Poulter, N. R., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01744-6 · Cited by 59
Guo, X., Sun, G., Xu, Y., Zhou, S., Song, Q., Li, Y., Ouyang, N., Li, G., Cheng, Z., Ye, N., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01391-1 · Cited by 55
Self-citationSeven‐action approaches for the management of hypertension in Asia – The HOPE Asia network
Kario, K., Chia, Y. C., Siddique, S., Turana, Y., Li, Y., Chen, C., Nailes, J. M., Minh, H. V., Buranakitjaroen, P., Cheng, H., et al. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14440 · Cited by 51
Self-citationPeng, X., Jin, C., Song, Q., Wu, S., & Cai, J. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.028762 · Cited by 52
Self-citationJCS 2023 Guideline on the Primary Prevention of Coronary Artery Disease
Fujiyoshi, A., Kohsaka, S., Hata, J., Hara, M., Kai, H., Masuda, D., Miyamatsu, N., Nishio, Y., Ogura, M., Sata, M., et al. (2024) · Circulation Journal · doi:10.1253/circj.cj-23-0285 · Cited by 60
McCarthy, C. P., Bruno, R. M., Rahimi, K., Touyz, R. M., & McEvoy, J. W. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.24173 · Cited by 56
Minh, H. V., Huy, T. V., Doan, L., & Tien, H. A. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14580 · Cited by 55
Unique characteristics of Asians with hypertension: what is known and what can be done?
Loo, G. J. M., Puar, T. H. K., Foo, R., Ong, T. K., Wang, T., Nguyen, Q. N., Chin, C. T., & Chin, C. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003706 · Cited by 43
“…by the Blood Pressure Lowering Treatment Trialists’ collaboration showed that pharmacological blood pressure reduction is 60–80 years old showed significantly lower rates of cardio-vascular events and death with a strict SBP control of 110– 130 mmHg (3.5 vs. 4.6%, HR 0.74; P ¼ 0.007) [51].”
BackgroundInfluentialSelf-citationKario, K., Tomitani, N., Wang, T.-D., Park, S., Li, Y., Shin, J., Tsoi, K., Chen, C.-H., Cheng, H.-M., Siddique, S., et al. (2023) · Hypertension Research · doi:10.1038/s41440-023-01397-6 · Cited by 40
Self-citationZhang, ., Zhong, Y., Wang, L., Yin, X., Li, Y., Liu, Y., Dai, Q., Tong, A., Li, D., Zhang, L., et al. (2022) · Hypertension Research · doi:10.1038/s41440-022-00852-0 · Cited by 43
Self-citationLifestyle modifications and non-pharmacological management in elderly hypertension
Tsai, H., Chuang, H., Liao, W.-H., Wang, Y.-J., Li, P., Wang, W., Liao, S., Yeh, C., Chen, P., Lai, T., et al. (2024) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2024.10.022 · Cited by 42
The critical issue linking lipids and inflammation: Clinical utility of stopping oxidative stress
Bale, B. F., Doneen, A. L., Leimgruber, P. P., & Vigerust, D. J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1042729 · Cited by 40
Kouidi, E. J., Hanssen, H., Anding‐Rost, K., Cupisti, A., Deligiannis, A. P., Grupp, C., Koufaki, P., Leeson, P., Segura‐Ortí, E., Craenenbroeck, A. H. V., et al. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae130 · Cited by 42
Application of artificial intelligence in hypertension
Cho, J. S., & Park, J. (2024) · Clinical Hypertension · doi:10.1186/s40885-024-00266-9 · Cited by 48
Guo, X., Ouyang, N., Sun, G., Zhang, N., Li, Z., Zhang, X., Li, G., Wang, C., Qiao, L., Zhou, Y., et al. (2024) · JAMA Cardiology · doi:10.1001/jamacardio.2024.1449 · Cited by 38
Self-citationYang, Q., Zheng, R., Wang, S., Zhu, J., Li, M., Wang, T., Zhao, Z., Xu, M., Lu, J., Chen, Y., et al. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.20954 · Cited by 38
Self-citationSanchez, R. A., Coca, A., Molina, D. I., Alcocer, L. A., Aristizábal, D., Barbosa, E. C. D., Brandão, A. A., Diaz-Velazco, M. E., Hernández-Hernández, R., López-Jaramillo, P. A., et al. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003899 · Cited by 52
Shibata, S., Kobayashi, K., Tanaka, M., Asayama, K., Yamamoto, E., Nakagami, H., Hoshide, S., Kishi, T., Matsumoto, C., Mogi, M., et al. (2022) · Hypertension Research · doi:10.1038/s41440-022-01134-5 · Cited by 37
Self-citationRen, Y., Wang, Z., & Wang, Q. (2023) · International Urology and Nephrology · doi:10.1007/s11255-023-03707-w · Cited by 37
Danaietash, P., Verweij, P., Wang, J., Dresser, G. K., Kantola, I. M., Lawrence, M. K., Narkiewicz, K., Schlaich, M. P., Bellet, M., & the PRECISION investigators (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14517 · Cited by 39
Intensive BP Control in Patients with CKD and Risk for Adverse Outcomes
Ku, E., McCulloch, C. E., Inker, L. A., Tighiouart, H., Schaefer, F. S., Wühl, E., Ruggenenti, P. L., Remuzzi, G., Grimes, B. A., & Sarnak, M. J. (2023) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000072 · Cited by 35
Pathophysiology, Diagnosis, and Management of Hypertension in the Elderly
Glazier, J. J. (2022) · International Journal of Angiology · doi:10.1055/s-0042-1759486 · Cited by 42
Fan, L., Ren, J., Chen, Y., Wang, Y., Guo, Z., Bu, P., Yang, J., Ma, W., Zhu, B., Zhao, Y., et al. (2022) · Trials · doi:10.1186/s13063-022-06086-2 · Cited by 39
Self-citationOutpatient management of essential hypertension: a review based on the latest clinical guidelines
Moiz, A., Zolotarova, T., & Eisenberg, M. J. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2338242 · Cited by 38
Wang, B. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12020046 · Cited by 42
“…Pressure Intervention in the Elderly Hypertensive Patients) study and the SPRINT (Systolic Blood Pressure Intervention Trial) have provided compelling evidence that more aggressive BP control may yield additional cardiovascular benefits, thereby prompting a reconsideration of BP targets [5,6].”
Yu, Y., Gu, M., Huang, H., Cheng, S., Deng, Y., Cai, C., Chen, X., Niu, H., Ning, X., & Hua, W. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03678-z · Cited by 33
Self-citationBlood pressure in heart failure management and prevention
Maeda, D., Dotare, T., Matsue, Y., TERAMOTO, K., Sunayama, T., Tromp, J., & Minamino, T. (2023) · Hypertension Research · doi:10.1038/s41440-022-01158-x · Cited by 34
Hsu, C., Saver, J. L., Ovbiagele, B. I., Wu, Y., Cheng, C.-Y., & Lee, M. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.0218 · Cited by 34
Deng, Y., Liu, W. Y., Yang, X., Guo, Z., Zhang, J., Huang, R., Yang, X., Yu, C., Yu, J., Cai, J., et al. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.20732 · Cited by 34
Self-citationLatest hypertension research to inform clinical practice in Asia
Kario, K., Mogi, M., & Hoshide, S. (2022) · Hypertension Research · doi:10.1038/s41440-022-00874-8 · Cited by 32
Self-citationBrazilian Guidelines for In-office and Out-of-office Blood Pressure Measurement – 2023
Feitosa, A. D. M., Barroso, W. K. S., Mion, D., Nobre, F. D., Gomes, M. A. M., Jardim, P. C. B. V., Amodeo, C., Oliveira, A. C., Alessi, A., Sousa, A. L. L., et al. (2024) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240113i · Cited by 46
Pedretti, R. F. E., Asteggiano, R., Gevaert, A. B., Bowen, T. S., Caselli, S., Cornelissen, V., Christodorescu, R., Derosa, G., Diévart, F., Kurpas, D., et al. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf175 · Cited by 41
Hypertension Across a Woman’s Life Cycle
Ghazi, L., Annabathula, R. V., Bello, N. A., Zhou, L., Stacey, R. B., & Upadhya, B. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01230-4 · Cited by 40
Lin, Z., Xiao, Z., Chen, W., Xu, W., Huang, C., Xie, J., Jin, M., Wei, X., He, S., Xie, Z., et al. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad083 · Cited by 32
Self-citationAbe, M., Hirata, T., Morito, N., Kawashima, M., Yoshida, S., Takami, Y., Fujimoto, T., Kawasoe, S., Shibukawa, T., Segawa, H., et al. (2024) · Hypertension Research · doi:10.1038/s41440-024-01939-6 · Cited by 31
Hypertensive heart disease in older patients: considerations for clinical practice
Camafort, M., Kasiakogias, A., Agabiti‐Rosei, E., Masi, S., Iliakis, P., Bénétos, A., Jeong, J., Lee, H., Muiesan, M. L., Sudano, I., et al. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.12.034 · Cited by 37
STEP to blood pressure management of elderly hypertension: evidence from Asia
Zhang, W., & Cai, J. (2022) · Hypertension Research · doi:10.1038/s41440-022-00875-7 · Cited by 34
Self-citationSarzani, R., Laureti, G., Gezzi, A., Spannella, F., & Giulietti, F. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221102754 · Cited by 33
Metadata
- Authors
- Zhang, W., Zhang, S., Deng, Y., Wu, S., Ren, J., Sun, G., Yang, J., Jiang, Y., Xu, X., Wang, T.-D., Chen, Y., Li, Y., Yao, L., Li, D., Wang, L., Shen, X., Yin, X., Liu, W., Zhou, X., Zhu, B., Guo, Z., Liu, H., Chen, X., Feng, Y., Tian, G., Gao, X., Kario, K., & Cai, J.
- Affiliations
- Shanxi Medical University (CN)
- Hebei North University (CN)
- Omron (Japan) (JP)
- Jichi Medical University (JP)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-09-30
- Volume
- 385
- Issue
- 14
- Pages
- 1268-1279
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3198533772
- Cited by
- 784
- References
- 47
- Citations by year
- 2026: 131 · 2025: 196 · 2024: 146 · 2023: 134 · 2022: 154 · 2021: 23
- FWCI
- 76.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81630014, 81825002)
- Beijing Outstanding Young Scientist Program (BJJWZYJH01201910023029)
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2016-I2M-1-006, CI2021A00920)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Keywords
- intensive blood pressure control, systolic blood pressure target, older adults, hypertension, cardiovascular risk reduction, stroke, acute coronary syndrome, acute decompensated heart failure, coronary revascularization, atrial fibrillation, cardiovascular mortality, renal outcomes, antihypertensive therapy, Chinese patients, SPRINT trial
- MeSH terms
- Aged, Aged, 80 and over, Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Female, Humans, Hypertension, Hypotension, Male, Middle Aged, Systole, Incidence, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.